扩散加权成像在喉癌和下咽癌诊断及治疗反应预测中的临床效用:系统综述与Meta分析
该系统综述与Meta分析共纳入16项研究,评估DWI在喉癌/下咽癌诊断、预后预测和治疗反应预测中的效用。9项诊断研究均能区分喉癌/下咽癌与良性病变,7项研究的Meta分析显示喉癌/下咽癌ADC值显著低于非恶性病变(SMD=-1.71,95%CI:[-2.00,-1.42],ADC截止值=1.2×10³ mm²/s)。预后预测研究中67%(4/6)基于治疗前ADC值准确预测结局,治疗反应预测研究中50%(2/4)成功预测;作者结论认为DWI对诊断有显著帮助,但预测预后和治疗反应的可靠性尚需进一步研究。
要点
- 喉癌/下咽癌的ADC值显著低于非恶性病变(SMD=-1.71,95%CI:[-2.00,-1.42])。
- Meta分析提示ADC截止值1.2×10³ mm²/s可用于区分喉癌/下咽癌与非恶性病变。
- 治疗前ADC值较高可能与预后良好相关,但预测可靠性尚需进一步研究。
核心结论
- DWI对喉癌/下咽癌的诊断有显著帮助;但DWI预测预后和治疗反应的可靠性尚需进一步研究。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Web of Science和Embase,共纳入16项研究,其中诊断研究9项,7项提供恶性和非恶性组织ADC值的研究纳入Meta分析(计算SMD及95%CI)。
关键影像表现/征象
- 喉癌/下咽癌的ADC值低于非恶性喉/下咽病变。
- 治疗前喉/下咽ADC值与良好结局呈正相关。
诊断标准与关键数值
- Meta分析显示喉癌/下咽癌ADC值显著低于非恶性病变,SMD=-1.71(95%CI:[-2.00,-1.42]),ADC截止值=1.2×10³ mm²/s。
临床应用与阅片要点
- DWI可用于辅助区分喉癌/下咽癌与良性喉/下咽病变,阅片时可结合ADC值评估。
- 治疗前ADC值可能有助于预后判断和治疗反应预测,但原文指出其可靠性尚需进一步研究。
局限性
- 原文结论指出,DWI预测喉癌/下咽癌患者预后和治疗反应的可靠性尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Laryngeal and Hypopharyngeal Carcinomas (LC/HPC) constitute about 24 % of head and neck cancers, causing more than 90,000 annual deaths worldwide. Diffusion-Weighted Imaging (DWI), is currently widely studied in oncologic imaging and can aid in distinguishing cellular tumors from other tissues. Our objective was to review the effectiveness of DWI in three areas: diagnosing, predicting prognosis, and predicting treatment response in patients with LC/HPC.
METHODS: A systematic search was conducted in PubMed, Web of Science, and Embase. A meta-analysis by calculating Standardized Mean Difference (SMD) and 95 % Confidence Interval (CI) was conducted on diagnostic studies.
RESULTS: A total of 16 studies were included. All diagnostic studies (n = 9) were able to differentiate between the LC/HPC and other benign laryngeal/hypopharyngeal lesions. These studies found that LC/HPC had lower Apparent Diffusion Coefficient (ADC) values than non-cancerous lesions. Our meta-analysis of 7 diagnostic studies, that provided ADC values of malignant and non-malignant tissues, demonstrated significantly lower ADC values in LC/HPC compared to non-malignant lesions (SMD = -1.71, 95 %CI: [-2.00, -1.42], ADC cut-off = 1.2 × 103 mm2/s). Furthermore, among the studies predicting prognosis, 67 % (4/6) accurately predicted outcomes based on pretreatment ADC values. Similarly, among studies predicting treatment response, 50 % (2/4) successfully predicted outcomes based on pretreatment ADC values. Overall, the studies that looked at prognosis or treatment response in LC/HPC found a positive correlation between pretreatment ADC values in larynx/hypopharynx and favorable outcomes.
CONCLUSION: DWI aids significantly in the LC/HPC diagnosis. However, further research is needed to establish DWI's reliability in predicting prognosis and treatment response in patients with LC/HPC.
引用
- Parsaei M, Sanjari Moghaddam H, Mazaheri P, et al. The clinical utility of diffusion-weighted imaging in diagnosing and predicting treatment response of laryngeal and hypopharyngeal carcinoma: A systematic review and meta-analysis. Eur J Radiol. 2024. PMID: 38878501. doi:10.1016/j.ejrad.2024.111550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。